C4 CRE investigators collaborate with colleagues in national and international committees and working groups, including:

  • Asia Oceania Research Organisation on Genital Infections on Genital Infections and Neoplasia (AOGIN)
  • Australian National Cervical Screening Program Quality and Safety Monitoring Committee
  • Australian NPAAC Cervical Screening Drafting Committee
  • Australian Regional Immunisation Alliance
  • Cancer Research Advisory Committee, Cancer Institute NSW
  • Cancer Screening Committee, Cancer Council Australia
  • Cervical cancer expert reference group for National Optimal Care Pathway. Cancer Council Victoria
  • Cervical Drafting Committee to undertake a review of the National Pathology Accreditation Advisory Committee document; Requirements for Laboratories Reporting Tests for the National Cervical Screening Program. The Department of Health
  • Epidemiology and Research in Cancer Biology, Groups. Instituto Nacional de Cancerologia, Bogota, Colombia. Prevention and Implementation Group
  • European Research Organization on Genital Infection and Neoplasia (EUROGIN)
  • Evaluation and Research Working Group for the Victorian Cancer Screening Framework (Department of Health, Victoria)
  • Expert Medical Panel at The Australian Cervical Cancer Foundation
  • Healthcare Services Advisory Committee, Cancer Council Australia
  • HPV Sub-committee of the New Zealand National Cervical Screening Program Technical Reference Group, Ministry of Health, New Zealand
  • HPV Surveillance Working Group to update the HPV Surveillance Plan – an integrated approach to monitoring the impact of HPV vaccination in Australia. The Department of Health
  • HPV Test Characteristics Expert Panel and Consultant to Cancer Care Ontario
  • HPV Testing for Primary Screening Project Technical Reference Group Ministry of Health, New Zealand
  • Improving Cancer Outcomes for Aboriginal Communities Working group
  • International Agency for Research on Cancer (IARC) Handbooks of Cancer Prevention, Advisory Group to Recommend an Update to the Working Procedures
  • International Agency for Research on Cancer (IARC) Working Group for Handbook 18 on Cervical Screening
  • International Papillomavirus Society
  • Medical & Scientific Committee of the Cancer Council of Victoria
  • National Centre for Immunisation Research and Surveillance Expert Advisory Committee for the evaluation of the National HPV Vaccination Program
  • National Cervical Screening Program Clinical Expert Panel
  • National Cervical Screening Program Self-Collection Expert Advisory Group, Department of Health
  • National Cervical Screening Program Self-Collection Working Group
  • National Health and Medical Research Council Grant Review Panels
  • National Pathology Accreditation Advisory Committee Self-Collect Validation Working Group
  • Ontario Cervical Screening Program Screening and Colposcopy Recommendations, Ontario Health
  • Pacific Friends of Global Health Advisory Board, University of Melbourne
  • PATH Single Dose HPV Vaccine Evaluation Consortium
  • Positive Life NSW’s HPV Working Group
  • Project Steering Committee, Australian Government – Cancer Australia: Using data to improve cervical cancer outcomes for Aboriginal and Torres Strait Islander women
  • Protocol Advisory Sub-Committee (PASC), a standing sub-committee of the Medical Services Advisory Committee (MSAC)
  • Public Health Committee, Cancer Council Australia
  • Quality and Safety Monitoring Committee’s Quality Framework Working Group, National Cervical Screening Program
  • Research and Data Advisory Group, Cancer Australia
  • Steering Committee, Cancer Council Victoria’s Eliminate Cervical Cancer Fund
  • Under-screened Program Steering Group (Department of Health, Victoria)
  • Victorian Cancer Agency Mid-Career Research Fellowship Evaluation Panel
  • Victorian Cancer Register Strategic Advisory Group
  • Victorian Renewal Advisory Committee
  • WHO Cervical Cancer Elimination Data Monitoring Group
  • WHO CIN Screen and Treat Update Guideline Development Group
  • WHO Director-General’s Expert Advisory Group on the Elimination of Cervical Cancer Working Party – Guidelines for the management of screen-detected abnormalities, screening in specific populations and investigation of abnormal vaginal bleeding, Cancer Council Australia
  • WHO Director-General’s Expert Advisory Group on the Elimination of Cervical Cancer Working Party – Guidelines for the management of screen-detected abnormalities, screening in specific populations and investigation of abnormal vaginal bleeding, Cancer Council Australia